BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND XPO1, DKFZp686B1823, 7514, ENSG00000082898, O14980, CRM1
20 results:

  • 1. crm1 expression: association with high prognostic value in laryngeal cancer.
    Özdaş T; Özdaş S; Canatar İ; Coşgun E; Şenyurt EB; Görgülü O
    Turk J Med Sci; 2023 Aug; 53(4):909-923. PubMed ID: 38031942
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular Modeling and In Vitro Evaluation of Piplartine Analogs against Oral Squamous Cell Carcinoma.
    Silva RHN; Machado TQ; da Fonseca ACC; Tejera E; Perez-Castillo Y; Robbs BK; de Sousa DP
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838660
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A mass spectrometry-based approach for the identification of Kpnβ1 binding partners in cancer cells.
    Okpara MO; Hermann C; van der Watt PJ; Garnett S; Blackburn JM; Leaner VD
    Sci Rep; 2022 Nov; 12(1):20171. PubMed ID: 36418423
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Verdinexor, a Selective Inhibitor of Nuclear Exportin 1, Inhibits the Proliferation and Migration of Esophageal cancer via xpo1/c-Myc/FOSL1 Axis.
    Ou L; Wang X; Cheng S; Zhang M; Cui R; Hu C; Liu S; Tang Q; Peng Y; Chai R; Xie S; Wang S; Huang W; Wang X
    Int J Biol Sci; 2022; 18(1):276-291. PubMed ID: 34975332
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nuclear transport proteins are secreted by cancer cells and identified as potential novel cancer biomarkers.
    van der Watt PJ; Okpara MO; Wishart A; Parker MI; Soares NC; Blackburn JM; Leaner VD
    Int J Cancer; 2022 Jan; 150(2):347-361. PubMed ID: 34591985
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Overview of Ocular Side Effects of Selinexor.
    Al-Zubidi N; Gombos DS; Hong DS; Subbiah V; Fu S; Ahnert JR; Piha-Paul SA; Tsimberidou AM; Karp DD; Bernstam FM; Naing A
    Oncologist; 2021 Jul; 26(7):619-623. PubMed ID: 33728727
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targeting xpo1 and PAK4 in 8505C Anaplastic Thyroid cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance.
    Khan HY; Ge J; Nagasaka M; Aboukameel A; Mpilla G; Muqbil I; Szlaczky M; Chaker M; Baloglu E; Landesman Y; Mohammad RM; Azmi AS; Sukari A
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905765
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Targeting the xpo1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas.
    Saenz-Ponce N; Pillay R; de Long LM; Kashyap T; Argueta C; Landesman Y; Hazar-Rethinam M; Boros S; Panizza B; Jacquemyn M; Daelemans D; Gannon OM; Saunders NA
    Sci Transl Med; 2018 Jun; 10(447):. PubMed ID: 29950445
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin.
    Garg M; Kanojia D; Mayakonda A; Ganesan TS; Sadhanandhan B; Suresh S; S S; Nagare RP; Said JW; Doan NB; Ding LW; Baloglu E; Shacham S; Kauffman M; Koeffler HP
    Sci Rep; 2017 Aug; 7(1):9749. PubMed ID: 28852098
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A 80-gene set potentially predicts the relapse in laryngeal carcinoma optimized by support vector machine.
    Yang B; Guo Q; Wang F; Cai K; Bao X; Chu J
    Cancer Biomark; 2017; 19(1):65-73. PubMed ID: 28269752
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of Novel Oncogenic Mutations in Thyroid cancer.
    Pitt SC; Hernandez RA; Nehs MA; Gawande AA; Moore FD; Ruan DT; Cho NL
    J Am Coll Surg; 2016 Jun; 222(6):1036-1043.e2. PubMed ID: 27010584
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Involvement of chromosome region maintenance 1 (crm1) in the formation and progression of esophageal squamous cell carcinoma.
    Yang X; Cheng L; Yao L; Ren H; Zhang S; Min X; Chen X; Zhang J; Li M
    Med Oncol; 2014 Sep; 31(9):155. PubMed ID: 25148895
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Elevated expression of the nuclear export protein, crm1 (exportin 1), associates with human oesophageal squamous cell carcinoma.
    van der Watt PJ; Zemanay W; Govender D; Hendricks DT; Parker MI; Leaner VD
    Oncol Rep; 2014 Aug; 32(2):730-8. PubMed ID: 24898882
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic and molecular characterization of esophageal squamous cell carcinoma.
    Lin DC; Hao JJ; Nagata Y; Xu L; Shang L; Meng X; Sato Y; Okuno Y; Varela AM; Ding LW; Garg M; Liu LZ; Yang H; Yin D; Shi ZZ; Jiang YY; Gu WY; Gong T; Zhang Y; Xu X; Kalid O; Shacham S; Ogawa S; Wang MR; Koeffler HP
    Nat Genet; 2014 May; 46(5):467-73. PubMed ID: 24686850
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Docetaxel, nedaplatin, and S-1 (DGS) chemotherapy for advanced esophageal carcinoma: a phase I dose-escalation study.
    Tanaka Y; Yoshida K; Osada S; Yamaguchi K; Takahashi T
    Anticancer Res; 2011 Dec; 31(12):4589-97. PubMed ID: 22199335
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells.
    Hasegawa H; Kakuguchi W; Kuroshima T; Kitamura T; Tanaka S; Kitagawa Y; Totsuka Y; Shindoh M; Higashino F
    Br J Cancer; 2009 Jun; 100(12):1943-8. PubMed ID: 19513080
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein.
    Knauer SK; Bier C; Schlag P; Fritzmann J; Dietmaier W; Rödel F; Klein-Hitpass L; Kovács AF; Döring C; Hansmann ML; Hofmann WK; Kunkel M; Brochhausen C; Engels K; Lippert BM; Mann W; Stauber RH
    Cell Cycle; 2007 Jun; 6(12):1502-9. PubMed ID: 17582222
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.
    Benzeno S; Lu F; Guo M; Barbash O; Zhang F; Herman JG; Klein PS; Rustgi A; Diehl JA
    Oncogene; 2006 Oct; 25(47):6291-303. PubMed ID: 16732330
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Akt1 contains a functional leucine-rich nuclear export sequence.
    Saji M; Vasko V; Kada F; Allbritton EH; Burman KD; Ringel MD
    Biochem Biophys Res Commun; 2005 Jun; 332(1):167-73. PubMed ID: 15896313
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
    Lu F; Gladden AB; Diehl JA
    Cancer Res; 2003 Nov; 63(21):7056-61. PubMed ID: 14612495
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.